Leerink Partners Adjusts Price Target on Boston Scientific to $55 From $60
MT newswire2026/10/09 13:4109:41 AM EDT, 10/09/2026 (MT Newswires) -- Boston Scientific (BSX) has an average rating of overweight and mean price target of $58.61, according to analysts polled by FactSet. (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us) Price: 42.06, Change: +0.04, Percent Change: +0.08
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
CIBC announces $1 billion offering of limited recourse capital notes
Saudi "Desert Davos" postponed to 2027: $50 billion signing window closes, narrative of "global business hub" suffers setback
The "Future Investment Initiative" summit in Saudi Arabia, known as the "Desert Davos," has announced its postponement. The 10th edition of the event, originally scheduled to take place in Riyadh from October 26 to 29, has been postponed until 2027. The delay is due to ongoing attacks by Houthi forces targeting locations within Saudi Arabia, including Riyadh Airport and the Saudi Aramco headquarters. According to the draft agenda, planned attendees included senior executives from financial giants such as Goldman Sachs, JPMorgan, and Blackstone.
BUZZ-Steel Dynamics stock falls as quarterly profit misses expectations
Coca-Cola Announces Dividend of R$ 0.29564105286 per Unit
Crypto prices
More
